Joint Meeting of the

ADVISORY COMMITTEE FOR PHARMACEUTICAL SCIENCE AND

THE DERMATOLOGIC AND OPHTHALMIC DRUGS ADVISORY COMMITTEE

 November 17, 2000

Federal Register Notice – November 17, 2000 Meeting   pdf   htm

FDA Background Information  pdf  doc

Draft Guidance for Industry: Topical Dermatological Drug Product NDAs and ANDAs -- In Vivo Bioavailability, Bioequivalence, In Vitro Release, and Associated Studies, June 1998